Regeneron is a biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. They are a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists their unique ability to repeatedly and consistently translate science into medicine has lead to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in their laboratories. Their medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases.
Regeneron believes that when the right idea finds the right team, powerful change is possible. As they work together to discover, invent, and develop biopharmaceutical medicines, they’re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health. Learn more about their life-changing medicines. Join them as they build a future they believe in.
"We follow the science to solve the human body’s most complex mysteries. From our rapid response efforts to infectious diseases to the complex world of oncology, we’ve invented new technologies and pioneered novel approaches to revolutionize how to make medicine."
